Nicoletta Cordani

13PUBLICATIONS
35CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 19, 2026
Palbociclib targets β-catenin for degradation and synergizes with KRAS or ERK5 inhibition in colorectal cancer preclinical models.

|Mar 13, 2025
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis.

Federica Malighetti, Matteo Villa, Alberto Maria Villa

|Oct 26, 2024
Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer.

Nicoletta Cordani, Daniele Nova, Luca Sala

|Mar 06, 2024
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients.

Matteo Villa, Federica Malighetti, Elisa Sala

|Feb 24, 2024
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer.

Alice Ilari, Viola Cogliati, Noorhan Sherif

|Feb 10, 2024
Edaravone: A Novel Possible Drug for Cancer Treatment?

Elisa Duranti, Nicoletta Cordani, Chiara Villa

Pageof 3

Frequent Collaborators

6 joint publications

Maria Grazia Cerrito

4 joint publications

Luca Mologni

4 joint publications

Diego Luigi Cortinovis

4 joint publications

Federica Malighetti